Resistance of Bacteroides isolates recovered among clinical samples from a major Costa Rican hospital between 2000 and 2008 to ß-lactams, clindamycin, metronidazole, and chloramphenicol;Resistencia a los ß-lactámicos, clindamicina, metronidazol y cloranfenicol de aislamientos de Bacteroides recuperados en muestras clínicas de un hospital costarricense, entre el año 2000 y el 2008

Revista Espanola de Quimioterapia

Volumn 25, Issue 4, 2012, Pages 261-265

  Cordero Laurent, Estela ^a   Rodríguez, César ^a   Rodríguez Cavallini, Evelyn ^a   Gamboa Coronado, María del Mar ^a   Quesada Gómez, Carlos ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Antibiotic resistance; Clindamycin; Costa Rica; Metronidazole

Indexed keywords

BETA LACTAM; BETA LACTAMASE INHIBITOR; CEFOTETAN; CHLORAMPHENICOL; CLINDAMYCIN; METRONIDAZOLE; TAZOBACTAM; TICARCILLIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTEROIDES; BROTH DILUTION; COSTA RICA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTEROIDES; BACTEROIDES INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; CHLORAMPHENICOL; CLINDAMYCIN; COSTA RICA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES;

EID: 84872741739     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Giamarellou H. Anaerobic infection therapy. Int J Antimicrob Agents 2000; 16:341-346.
2. Goldstein EJC. Clinical Anaerobic infections. Anaerobe 1999; 5:347-50.
3. Quesada-Gómez C, Gamboa-Coronado MM, Rodríguez-Cavallini E. Bacterias anaerobias como agentes etiológicos de infecciones intraabdominales en un hospital de Costa Rica. Rev Panam Infect2008; 10:13-7.
4. Lazarovitch T, Freimann S, Shapira G, Blank H. Decrease in anaerobe-related bacteraemias and increase in Bacteroides species isolation rate from 1998 to 2007: A retrospective study. Anaerobe 2010; 16:201-05.
5. Quesada-Gómez C, Rodríguez-Cavallini E, Gamboa-Coronado MM. Bacterias anaerobias en muestras clínicas de pacientes de un hospital regional de adultos de Costa Rica. Rev Biomed 2007; 18:89-95.
6. Ulger N, Celik C, Cakici O, Soyletir G. Antimicrobial susceptibilities of Bacteroides fragilis and Bacteroides thetaiotaomicron strains isolated from clinical specimens and human intestinal microbiota. Anaerobe 2004; 10:255-9.
7. Jamal W, Shahin M, Rotimi VO. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007. Anaerobe 2010; 16:1-5.
8. Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RMF, Wexler HM. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb Pathogenesis 2007; 43:78-87.
9. Boente RF, Ferreira LQ, Falcão LS, Miranda KR, Guimarães PLS, Santos-Filho J, Vieira JMB, Barroso DE, Emond JP, Ferreira EO, Paula GR, Domingues RMCP. Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains. Anaerobe 2010; 16:190-4.
10. Falagas ME, Siakavellas E. Bacteroides, Prevotella and Porphyromonas and species: a review of antibiotic resistance and therapeutic options. Int J Antimicrob Agents 2000; 15:1-9.
11. Marina M, Ivanova M, Kantardjiev T. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria. Anaerobe 2009; 15:127-32.
12. Fang H, Hedberg M, Edlund C, Nord CE. Identification of the metallo-β-lactamase gene from clinical isolates of Bacteroides. Anaerobe 1999; 5:431-4.
13. Citron DM, Tyrrell KL, Warren YA, Fernandez H, Merriam CV, Goldstein EJC. In vitro activities of tinidazole and metronidazole against Clostridium difficile, Prevotella bivia and Bacteroides fragilis. Anaerobe 2005; 11:315-7.
14. Oh H, Hedberg M, Edlund C. Efflux-mediated fluoroquinolone resistance in Bacteroides fragilis the Group. Anaerobe 2002; 8:277-82.
15. Betriu C, Culebras E, Gómez M, López F, Rodríguez-Ávila I, Picazo JJ. Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain. Antimicrob Agents Chemother 2008; 52:2686-90.
16. Behra-Miellet J, Calvet L, Dubreuil L. A Bacteroides thetaiotaomicron porin that could take part in resistance to β-lactams. Int J Antimicrob Agents 2004; 24:135-43.
17. Hedberg M, Bush K, Bradford PA, Bhachech N, Edlund C, Tuner K, Nord CE. The role of penicillin-binding proteins for β-lactam resistance in a β-lactamase producing Bacteroides uniformis strain. Anaerobe 1996; 2:111-5.
18. Snydman DR, Jacobus NV, Mcdermott LA, Supran S, Cuchural GJ, Finegold S, Harrell L, Hecht DW, Iannini P. Multicenter study of susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996. Antimicrob Agents Chemother 1999; 43:2417-22.
19. Hecht DW. Anaerobes: Antibiotic resistance, clinical significance and the role of susceptibility testing. Anaerobe 2006;12:115-21.
20. Rodríguez-Cavallini E, Vargas P, Rodríguez C, Quesada-Gómez C, Gamboa-Coronado MM. Phenotypic identification of over 1000 isolates of anaerobic bacteria recovered between 1999 and 2008 in a major Costa Rican hospital. Clin Microbiol Infect 2010; 17:1043-7.
21. Carlier JP, Bedora-Faure M, K'ouas G, Alauzet C, Mory F. Proposal to unify Clostridium orbiscindens Winter et al. 1991 and Eubacterium plautii (Séguin 1928) Hofstad and Aasjord 1982, with description of Flavonifractor plautii gen. nov., comb. nov., and reassignment of Bacteroides capillosus to Pseudoflavonifractor capillosus gen. nov., comb. nov. Int J Syst Evol Microbiol 2010; 60:585-90.
22. Sakamoto M, Benno Y. Reclassification of Bacteroides distasonis, Bacteroides goldsteinii and Bacteroides merdae as ParaBacteroides distasonis gen. nov., comb. nov., Parabacteroides goldsteinii comb. nov. and Parabacteroides merdae comb. nov. Int J Syst Evol Microbiol 2006; 56:1599-605.
23. Clinical and Laboratory Standards Institute (CLSI), M11-A7. Methods for antimicrobial susceptibility testing of anaerobic bacteria: 7th edition. Wayne, PA: CLSI; 2007.
24. Quirós-Quesada M, Rodríguez C, Rodríguez-Cavallini E. Resistencia antimicrobiana en bacterias del grupo Bacteroides fragilis aisladas a partir de muestras diarreicas de pacientes pediátricos y geriátricos costarricenses. Rev Med UCR 2008; 2:6.
25. Rodríguez E, Gamboa MM, Rodríguez C, Vargas P. Grupo Bacteroides fragilis en heces humanas no diarreicas y su sensibilidad antimicrobiana. Rev Esp Quimioterap 2006; 19:357-62.
26. Katsandri A, Papaparaskevas J, Pantazatou A, Petrikkos GL, Thomopoulos G, Houhoula DP, Avlamis A. Two cases of infections due to multidrug-resistant Bacteroides fragilis group strains. J Clin Microbiol 2006; 44:3465-7.
27. Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM. Genetics analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis. Clin Microbiol Infec 2006; 13:183-9.
28. Snydman DR, Jacobus NV, McDermott LA, Ruthazer R, Golan Y, Goldstein EJC, Finegold SM, Harrell LJ, Hecht DW, Jenkins SG, Pierson C, Venezia R, Yu V, Rihs J, Gorbach SL. National survey on the susceptibility of Bacteroides fragilis group: Report and analysis of trends in the United States from 1997 to 2004. Antimicrob Agents Chemother 2007; 51:649-55.
29. Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003. Antimicrob Chemother 2006; 57:992-8.
30. Avelar KE, Otsuki K, Vicente AP, Vieira JM, Paula GR, Domingues RM, Ferreira MC. Presence of the cfxA gene in Bacteroides distasonis. Res Microbiol 2003; 154:369-74.
31. Nakano V, Padilla G, Marques MV, Ávila-Campos MJ. Plasmid-related β-lactamase production in Bacteroides fragilis strains. Res Microbiol 2004; 155:843-6.
32. Wexler HM. Bacteroides fragilis: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007; 20:593-621.
33. Sóki J, Edwards R, Hedberg M, Fang H, Nagy E, Nord CE. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Int J Antimicrob Agents 2006; 28:497-502.
34. Roberts M. Acquired tetracycline and/or macrolide-lincosamide-streptogramin resistance in anaerobes. Anaerobe 2003; 9:63-9.
35. Shoemaker NB, Vlamakis H, Hayes K, Salyers AA. Evidence for extensive resistance gene transfer among Bacteroides and among Bacteroides and other genera in the human colon. Appl Environ Microbiol 2001; 67:561-8.
36. Koru O, Ozyurt M. Determination of antimicrobial susceptibilities of clinically isolated anaerobic bacteria by E-test, ATB-ANA and agar dilution. Anaerobe 2008; 14: 161-5.
37. Boza R. Uso de agentes antimicrobianos en infecciones por bacterias anaerobias. Rev Cost Cienc Med 1985; 6:39-50.